Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2150249 Title: Gebruik van benzo-gecondenseerde heterocylische sulfamidederivaten voor de behandeling van migraine

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
077570596
WO application number:
US2007062241
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
2150249
WO publication number:
WO 2007/095618
1rst applicant's nationality:
Translation language:
Dutch
EPO publication language:
English
SPC number:

Dates

Filing date:
15/02/2007
Grant date:
24/04/2013
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
31/05/2013
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
24/04/2013
EP B1 publication date:
24/04/2013
EP B2 publication date:
EP B3 publication date:
Lapsed date:
28/02/2015
Expiration date (if granted and all annual fees paid):
15/02/2027

Applicant

Name:
Janssen Pharmaceutica N.V.
Legal Form:
From:
24/04/2013
Address:
Turnhoutseweg 30, 2340, Beerse, Belgium (BE)
To:

Agent

Name:
BRAS Piet
Legal Form:
From:
31/05/2013
Address:
Koninginnegracht 19, 2514 AB, DEN HAAG, Netherlands (NL)
To:

Inventor

Name:
SMITH-SWINTOSKY, Virginia L.
Legal Form:
Address:

Priority

1

Priority patent number:
773764
Priority date:
15/02/2006
Priority country:
United States (US)

2

Priority patent number:
674021
Priority date:
12/02/2007
Priority country:
United States (US)

Classification

Main IPC class:
A61K 31/353;
IPC or IDT classification:
A61K 31/357; A61K 31/36; A61P 25/06;

Publication

Bulletin

1

Bulletin heading:
EP3
Journal edition number:
2013/05
Publication date:
16/09/2019
Description:
Contains data concerning European patents granted for Belgium and published (B1 publication) in English and for which a translation in Dutch, French or German was filed under the Belgian Patent Laws

2

Bulletin heading:
VRV
Journal edition number:
2015/08
Publication date:
16/09/2019
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
14/02/2014
Last annual fee paid number:
8
Last annual fee paid amount:
125 Euro
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type
31/05/2013 General Document (TP - T:Traduction Originale plus Pouvoir) 69 PDF /9/4/2/0/5/0612150249/migrated-docs/077570596_1_309006.pdf